Company
Allakos Inc. (0001564824)
Standardized SEC financial data for Allakos Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001564824 · Pharmaceutical Preparations.
Return on equity
-0.1%
Free cash flow
-$93.7M
Current ratio
4.81×
EPS (diluted)
$-1.30
Income statement
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| R&D expense | $61.9M | $105.5M | $196.3M | $265.1M | $150.9M | $79.9M |
| SG&A expense |
Balance sheet
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $495.9M | $659.0M | $424.2M | $279.8M | $170.8M | $80.8M |
| Total current assets |
Cash flow
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$63.0M | -$113.9M | -$207.9M | -$280.0M | -$116.5M | -$93.6M |
| Capital expenditures |
Get 0001564824 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001564824/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001564824/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"